Healthcare Analytics Market ~27.1% CAGR Presume To Grow worldwide by 2024

Healthcare analytics offers the macro and micro level insights into hospital management, patient records, costs, diagnoses, and more in the burgeoning healthcare industry. Real-time information provided by healthcare analytics, help managers to make decisions, deliver actionable insights, and thus to operate in a better fashion.

Healthcare analytics is revolutionizing pharmaceutical organizations as well. Using more data and analytics, pharmaceutical organizations can assure their formulations positively. As a result, the uptake of healthcare analytics solutions is widening rapidly, leading to an increase in the size of its market.

Moreover, the latest trend of increasing collaboration between healthcare organizations and pharmaceutical companies to improve treatment plans is escalating the market on the global platform, revolutionizing the healthcare sector, completely.

Considering the exponential traction that the market is garnering currently, Market Research Future (MRFR) in its recently published study analysis asserts that the global healthcare analytics is poised to demonstrate significant growth registering a staggering double-digit CAGR of 27.1% throughout the forecast period (2019-2024). In the year 2018, the market had valued at USD 12,126.70 MN.

The demand to curtail healthcare costs is playing a vital role in the overall growth of the market. Additional factors that are bolstering the growth of the market include the high adoption of technological advancements in the field of healthcare and the availability of low-cost technology that improves patient care by improving existing procedures, providing better services.

Key Players

Key players leading the global healthcare analytics market include

• Cerner
• SAS Institute Inc.
• Allscripts Healthcare Solutions
• IBM
• Inovalon
• Wipro
• Cotiviti
• Health Catalyst
• Citiustech
• Mckesson
• Oracle
• Optum
• SCIO Health Analytics
• Medeanalytics
• Vitreoshealth
• 
  

Segmentation

For a better understanding, the report has been segmented into six key dynamics: -

By Type : Descriptive Analytics, Prescriptive Analytics, Predictive Analytics, and Cognitive Analytics.

By Component : Software and Services.

By Delivery Model : On-premise and On-demand.

By Application : Financial Analytics (Claims Processing, Payment Integrity & Fraud, Revenue Cycle Management (RCM), Waste & Abuse (FWA), Risk Adjustment & Assessment), Clinical Analytics (Quality Improvement & Clinical Benchmarking, Clinical Decision Support (CDS)), Operational & Administrative Analytics, and Population Health Analytics among others.

By End-user : Payers (Private Insurance Companies, Employers and Private Exchanges, Government Agencies,) and Providers (Hospitals & Clinics, Post-Acute Care Organizations, Ambulatory Settings), among others.

By Regions : Europe, North America, Asia Pacific, and the Rest-of-the-World.

Regional Market Summary

North America, heading with the presence of major players, accounts for the leading region in the global healthcare analytics market.  Rapid technological advancements in RCM and clinical analytics and increasing adoption of healthcare IT drive the regional market.  Additional factors that are bolstering growth in the regional market include the rising government initiatives to reduce medical errors and the use of big data and mHealth solutions. Also, increased focus on big data management & analysis, the establishment of healthcare policies by the federal government, and early emergence and adoption of healthcare analytics across the region would fuel the growth of the market during the forecast period.

The healthcare analytics market in the European region accounts for the second-largest market, globally. Factors such as government support and the presence of a well-established healthcare sector foster market growth in the region. Moreover, the increasing number of healthcare infrastructures and the healthcare insurance companies are fueling the increase in the regional market. 

The Asia Pacific healthcare analytics market is emerging as a profitable market globally. Factors such as vast technological advancements and the increasing demand to reduce medical errors are propelling the growth in the regional healthcare analytics market. With the several niche market players trying to leverage the share in the regional market, the number of technology providers is also expected to increase over the forecast period.

Moreover, factors such as the increasing patient pool drive the growth of the regional market, creating a huge demand for healthcare analytics in the region. The market is majorly propelled by some of the rapidly developing countries such as India and China.

Browse Complete Research Report @

https://www.marketresearchfuture.com/reports/healthcare-analytics-market-7819

Table Of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Typology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

TOC Continued….

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hepatitis B Treatment Market - Size, Research Report and Industry Analysis – Market Research Future

The global Hepatitis B Treatment Market is expected to grow at an approximate CAGR of 5.3% during the forecast period, 2018–2024.

Hepatitis B is a viral infection caused by a hepatitis B virus. This infection lasts for a longer period and can cause many other complications, such as scarring in the liver, liver cancer or liver failure. The person suffering from hepatitis B faces various symptoms such as fever, fatigue, nausea, and muscle aches. The other symptoms include jaundice, swelling in the legs, poor appetite, drowsiness and many more. The key factors contributing the market growth are growing geriatric population, increasing the prevalence of viral infection and growing sexually transmitted diseases among the population contribute to driving the market growth. The World Hepatitis Alliance (WHA), 2017 reported that 52 million children across the world are living with viral hepatitis. Such a huge population suffering from Hepatitis boosts the market growth.

However, the factor such as the side effects or complication caused due to treatment may hamper the market growth. 

Global Hepatitis B Treatment Market: Competitive Landscape

Some of the key players in the global Hepatitis B Treatment Market are

• Accord Healthcare Inc.
• Apotex Corp.
• Arbutus Biopharma
• Arrowhead Pharma
• Aurobindo Pharma Limited
• Bristol-Myers Squibb Company
• Gilead Sciences, Inc.
• GlaxoSmithKline
• Lupin Pharmaceuticals, Inc.
• Merck & Co., Inc.
• Par Pharmaceutical, Inc.
• Teva Pharmaceuticals
• Zydus Pharmaceuticals

Hepatitis B Treatment Market Segmentation

The global Hepatitis B Treatment Market is segmented on the basis of type, treatment, distribution channel, and region.

Based on type, the market is segmented into acute and chronic. On the basis of treatment, the global Hepatitis B Treatment Market is segmented into immune modulator drugs, antiviral drugs, vaccine, and surgery  (liver transplant). The immune modulator drugs are further sub-segmented into pegylated interferon and interferon alpha. The antiviral drugs are sub-segmented into tenofovir disoproxil, entecavir, telbivudine, lamivudine, and others. By distribution channel, the market is segmented into hospital & retail pharmacies and online pharmacies.

Hepatitis B Treatment Market Regional Analysis

The Americas dominates the global market for Hepatitis B Treatment Market. Factors such as the presence of a large number of healthcare companies, increasing geriatric population and high healthcare expenditure among the population within the Americas drives the market. The National Vaccine Information Center reported 3,370 cases of hepatitis B were reported in the US in 2015.

Following similar trends, Europe stood second in the global Hepatitis B Treatment Market market. The increased prevalence of viral diseases and growing healthcare expenditure in this region boost market growth. Also, the presence of developed economies, increasing healthcare facilities, and rising government funding for healthcare boost market growth. Asia Pacific was the fastest growing region for the global Hepatitis B Treatment Marketin 2017. This can be attributed due to the increasing incidences of HIV infection and rising demand for the treatment of viral infection among the population boosts market growth. 

On the other hand, the Middle East and Africa holds the least share in the global Hepatitis B Treatment Market market. The poor economies within the African region and lack of awareness about the treatment methods hinder the market growth.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Treatment Trends & Assessment

        TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/hepatitis-b-treatment-market-7817

About US:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Soft Tissue Repair Market Outlook 2023: Market to Grow at a High Volume

The Global Soft Tissue Repair Market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5200 million in 2017 and is projected to register a CAGR of 6.2% over the forecast period.

The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant. The xenograft implant is designed for the surgical repair of damaged or ruptured membranes.

Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market.

However, the high cost of advanced equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period.

Segmentation

The global soft tissue repair market is segmented based on product, application, end user, and region.

the global market for soft tissue repair, by product, is segmented into fixation products, tissue patch/match, laparoscopic instrument, and others. The fixation products segment is further classified as a suture, suture anchors, and interference screw. The tissue patch/match segment is further classified as biological, and synthetic. The biological segment includes allograft and xenograft.

Based on application, the market is segmented into orthopedic surgery, skin repair, hernia repair, vaginal sling repair, dental reconstruction, cardiovascular surgery, breast reconstruction, and others.

Based on end user, the market is segmented into hospitals, clinics, research & academic institutes, and others.

In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.

The soft tissue repair market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European soft tissue repair market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The soft tissue repair market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The soft tissue repair market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

The Americas dominated the global market for soft tissue repair owing to the increasing healthcare expenditure presence of major market players and rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058.

In 2017, it was estimated that Europe stood second in the global soft tissue repair market. Robust research and development (R&D) sector along with the availability of funding opportunities in research and innovation will support the market growth.

Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to increasing demand for medical technology, growing health awareness, and growing aging population coupled with the rising prevalence of orthopedic diseases in India, Japan, and Australia. For instance, according to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), in 2016, around 12.4% of the population in the region was 60 years or older and is projected to reach to more than 1.3 billion by 2050.

On the other hand, the Middle East and Africa held the least share in the global soft tissue repair market due to the low economic development, especially within the African region.

Key Players

Some of the key players in the global soft tissue repair market are Stryker Corporation, C.R. Bard, Inc., Arthrex, Inc., Integra LifeScience Corporation, Depuy Synthes, Smith & Nephew plc, Allergan Plc., Athersys, Inc., CryoLife, Inc., Medtronic Plc., Organogenesis Inc., Zimmer Biomet Holdings, Inc., Lifenet Health, Inc., American Medical Systems Inc., U.S. Stem Cell, Inc., Wright Medical Group, Inc., Isto Biologics, and others.

Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures at @ https://www.marketresearchfuture.com/reports/soft-tissue-repair-market-7810

Detailed Table Of Contents

1 Report Prologue

2 Introduction

2.1 Definition 

2.2 Scope Of The Study 

2.2.1 Research Objective 

2.2.2 Assumptions 

2.2.3 Limitations 

2.3 Market Structure 

2.4. Market Segmentation 

3 Research Methodology

3.1 Research Process 

3.2 Primary Research 

3.3 Secondary Research 

5 Market Dynamics

4.1 Drivers 

4.2 Restraints 

4.3 Opportunities 

4.4 Mega Trends 

4.5 Macroeconomic Indicators 

5 Market Factor analysis

5.1 Porter’s Five Force Analysis 

5.1.1 Bargaining Power Of Buyer 

5.1.2 Bargaining Power Of Supplier 

5.1.3 Threat From Substitute 

5.1.4 Threat From A New Entrant 

5.1.5 Intensity Of Competitive Rivalry 

TOC Continued…

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Clinical Trials Market Worldwide Key Players Revenue, Share and Forecasts to 2023

Clinical Trials Market - Highlights

Clinical trial is a research study which involve people (healthy volunteers or patients) to test the safety and efficacy of a new treatment or medicine. In healthcare industry clinical trials are performed for medicine, medical devices which includes hearing aid and surgical procedure.

The key factors driving the clinical trial industry includes rising prevalence of diseases, high R&D expenditure of the pharmaceutical industry, and growth of new treatments such as personalized medicine is supporting to grow the market. However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.

The market for global clinical trial market is estimated to grow at an approximate CAGR of 5.7% from 2017 to 2023

However, factors such as lack of skilled workforce clinical research, lower healthcare reimbursement in the developing countries and stringent regulations for patient enrollment, hinder the market growth.

Key Players:

Charles River Laboratories, Paraxel International Corporation, Quintiles IMS, ICON plc, SGS SA, Eli Lilly and Company, Novo Nordisk A/S, Clinipace, Laboratory Corporation of America, Pfizer and Others are some of the major players for global clinical trials market.

Segmentation:

The global clinical trials market is segmented on the basis of phase, study design, indication and end users. On the basis of the phase, the market is categorized into phase I, phase II, phase III, and phase IV. On the basis of study design, the global clinical trials market is segmented into interventional, observational and expanded access. On the basis of indication, the global clinical trials market is segmented into autoimmune/inflammation, pain management, oncology, central nervous system (CNS) condition, diabetes, obesity, cardiovascular and others. On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.

On the regional basis, the global clinical trial market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global clinical trial market owing to the presence of well-established healthcare sector, growing prevalence of high diseases and also increasing funding from government. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to increasing geriatric population with either one or more disease and favorable environment such as low operating cost, skilled technician and increasing healthcare facilities provides favorable scenario for the market growth.

Regional Analysis:

The Americas dominate the global  clinical trial market owing to the presence of major pharmaceutical and biotech companies with R&D units in America and increasing patient population suffering from cardiac problem boost the clinical trial market in this region. Moreover, rising healthcare expenditure and presence of developed economies like U.S. and Canada fuels the market growth.

Europe is second in the global clinical trial market owing to increasing government support, rising clinical trail facilities both in private and government sector increases the clinical trial market in Europe.

Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and standard regulations related to healthcare industry promotes the manufactures to establish R&D unit in this region which drives the market with the region. The Middle East & Africa has the least share in the global clinical trial market owing to the presence of poor economies and stringent government policies, especially in the African region.

Browse Complete 110 Pages Premium Research Report Enabled With Respective Tables And Figures At https://www.marketresearchfuture.com/reports/clinical-trials-market-7787

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

TOC Continued...!

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Aortic Aneurysm Market Share Analysis, Strategies, Revenue and Forecasts to 2023

The global aortic aneurysm market held a market value of USD 2,357.6 million in 2017 and is projected to grow at a CAGR of 8.4% over the forecast period. An aortic aneurysm is an abnormal enlargement or bulging of the wall of the aorta. Aortic aneurysm has two types such as an abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). An abdominal aortic aneurysm is an aneurysm in the part of the aorta that passes through the abdomen while thoracic aortic aneurysm is an aortic aneurysm that presents mainly in the thorax.

Some of the market growth factors include rising prevalence of tobacco smoking in the developed and developing countries, worldwide growing elderly population coupled with the increasing burden of cardiovascular diseases, favorable reimbursement scenarios for surgical treatment of aortic aneurysms, and mounting technological advancements in products. In contrast, the presence of low reimbursement rates in the developing countries and higher cost of aortic aneurysm treatment and devices are anticipated to hinder the market growth during the next five years.

Segmentation

The global aortic aneurysm market has been segmented into type, product, treatment, end user, and region.

By type, the market has been segmented into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA).

On the basis of product, the market has been divided into stent-grafts, catheters, and others.

By treatment, the market has been classified into endovascular aneurysm repair (EVAR) and open surgical repair (OSR).

Based on end user, the market has been categorized into hospitals and clinics, ambulatory surgery centers (ASCs), and others.

Key Players

Some of the spearheading players in the global aortic aneurysm market are

• Medtronic plc
• Cook Medical
• Terumo Medical Corporation
• Microport Scientific Corporation
• MAQUET Holding B.V. & Co. KG
• Endologix Inc.
• L. Gore & Associates
• Lombard Medical Limited
• JO0TEC AG (CryoLife Inc.)
• and Cardinal Health Inc.

Regional Analysis

The global aortic aneurysm market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. Based on region, the Americas would continue its supremacy over the forecast period attributed to the presence of sophisticated medical and healthcare infrastructure and major market participants, higher spending on the healthcare, and frequent launches of novel devices in the US and Canada. For instance, in 2015, Cook Group Incorporated launched its Zenith Alpha abdominal endovascular graft in Canada.

Europe would be the second-largest value contributor in the aortic aneurysm market due to the highest prevalence of tobacco smoking and the presence of favorable initiatives by several organizations to reduce the burden of aortic aneurysm. For instance, the World Health Organization (WHO) stated that presently, Europe has the highest prevalence of tobacco smoking among adults (28%) and some of the highest prevalence of tobacco use by adolescents.

Browse Complete 100 Pages Premium Research Report Enabled with 82 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/aortic-aneurysm-market-7776

Asia-Pacific is likely to witness the fastest market growth during the forecast period due to growth in increasing geriatric population and prevalence of cardiovascular diseases & hypertension, and growing awareness about aortic aneurysm treatment, and developing healthcare infrastructure in India, China, and Australia. For instance, WHO reported that one million people in the World Health Organization Western Pacific Region die each year from cardiovascular disease caused by tobacco use and more than 1 in 5 cardiovascular diseases, such as heart attack and stroke, result from smoking?

The Middle East & Africa has the least share of the global aortic aneurysm market. In addition, the major market share of the region would be held by the Middle Eastern region. Several studies reported that aortic aneurysm is very rare in the Middle East and very few lives are threatened by deadly aortic aneurysms annually in the Middle East region.

Table Of Contents

Chapter 1 Report Prologue

Chapter 2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

TOC Continued…

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Medical Terminology Software Market Outlook 2023 – Market Research Future

It is estimated that the global medical terminology software market is expected to register a CAGR ~20% during the forecast period of 2018–2023.

Medical terminology software industry will witness a strong growth it is beneficial in enhancing the efficiency of a laboratory by providing operators with increased inventory control and tracking, including greater flexibility to address changing needs of the laboratory and business conditions.

The rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations are anticipated to fuel the growth of the market. On the other hand, the restricted access to systems in emerging countries is expected to hamper the growth of the market.

Segmentation:

The global medical terminology software market is segmented on the basis of product & service, application, and end user.

The medical terminology software market, by product & service, is categorized into services and platforms.

Based on application, the medical terminology software market is segmented into data aggregation, reimbursement, public health surveillance, data integration, decision support, clinical trials, quality reporting, and clinical guidelines.

On the basis of end user, the market is segmented into healthcare providers, healthcare payers, and healthcare IT vendors. The healthcare providers subcategory is further divided into healthcare service providers and health information exchanges. The healthcare payer’s subcategory is further divided into private payers and public payers

Key Players:

Some of the key players in the global medical terminology software market are

• Wolters Kluwer
• 3M
• Intelligent Medical Objects
• Apelon
• Clinical Architecture
• CareCom
• Bitac
• B2i Healthcare
• BT Clinical Computing
• and HiveWorx

Medical Terminology Software Market: Highlights

It is estimated that the global medical terminology software market is expected to register a CAGR ~20% during the forecast period of 2018–2023.

Medical terminology software industry will witness a strong growth it is beneficial in enhancing the efficiency of a laboratory by providing operators with increased inventory control and tracking, including greater flexibility to address changing needs of the laboratory and business conditions.

The rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations are anticipated to fuel the growth of the market. On the other hand, the restricted access to systems in emerging countries is expected to hamper the growth of the market.

The global medical terminology software market is conquered by several players. The key players are involved in new product launches, as well as strategic collaborations to brace their position in the market. For instance, in 2016, Wolters Kluwer (Netherlands) announced a partnership with HealthCore, Inc., (US), a clinical outcomes research subsidiary of Anthem, Inc. (US), to provide data normalization services to the California Integrated Data Exchange through its health language enterprise terminology management platform. This initiative is anticipated to open new avenues for the firm to cater to the untapped markets in this region.

Browse Complete 160 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/medical-terminology-software-market-7785

Regional Analysis:

The Americas is expected to hold a major share in the global medical terminology software market can be attributed to the growing demand for accurate data exchange between healthcare providers and payers to streamline workflows in the region.

Europe is expected to hold the second largest share in the medical terminology software market due to the increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming years.

Asia-Pacific was projected to be the fastest growing region for the global medical terminology software market due to the high adoption of HCIT technologies, regulatory requirements regarding patient safety. The Middle East and Africa holds the least share in the market due to fewer initiatives taken by the government.

Table Of Contents

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

TOC Continued…

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Dental Industry Market Legend Key Players Analysis, Share, Revenue and Forecasts Till 2023

The dental industry includes the diagnosis, treatment, instruments, and devices related to oral health. There are various problems related to oral health such as pigmentation in gums, teeth cavity, brown or discoloration of teeth and others which are treated under the dental, medical industry. The key factors driving the dental industry include rising aging population globally, growing demand for cosmetic dentistry treatments, and increasing demand for dental procedures.

However, factors such as low dental insurance coverage compared to general health, lack of technological awareness and grey market of dental products, hinder the market growth. The market for the global dental industry is estimated to grow at an approximate CAGR of 7.6% from 2018 to 2023.

Global Dental Industry Market: Competitive Landscape

Some of the key players in the global Dental Industry Market are

• Henry Schein Inc.
• Hu-Friedy Mfg Co.
• Ivoclar Vivadent AG
• Nakanishi Inc., Patterson Companies Inc.
• Dentsply Sirona
• Ultradent Products Inc.
• Young Innovations Inc.
• 3M Company
• Zimmer Biomet
• Kangda Medical

Dental Industry Market Segmentation

The global dental industry market is segmented on the basis of discipline, consumables and end users. On the basis of the discipline, the market is categorized into restorative dentistry, endodontics, prosthodontics, orthodontics, periodontics, and oral surgery.

On the basis of consumables, the global dental industry market is segmented into dental burs, whitening material, dental biomaterial, gingival retraction material, dental anesthetic, dental syringe, and endodontic supplies. The dental biomaterial segment is sub-segmented into dental cement, dental bone graft and regenerative tissue material. The gingival retraction material is further sub-segmented into gingival hemostatic agents, gingival retraction cord and gingival retraction paste/gels/cap. The dental anesthetic is further sub-segmented into topical anesthetics, injectable anesthetic, and non-injectable anesthetic. The dental syringe is sub-segmented into a non-disposable syringe and disposable syringes/ safety syringes. The endodontic supplies are sub-segmented into files and cement. On the basis of the end-user, the market is segmented into dental hospitals & clinics, dental institutes and dental academic and research institutes.

On a regional basis, the global dental industry market in the Americas is segmented into two major regions, i.e., North America and Latin America. The North American region is likely to hold the major share in the global dental industry market owing to the presence of well-established healthcare sector, growing prevalence of dental problems and also high disposable income. Additionally, the Asia-Pacific region is anticipated to be the fastest growing region due to the rising awareness about treatment and increasing healthcare facilities provides a favourable scenario for market growth.

Dental Industry Market Regional Analysis

The Americas dominate the global dental industry market owing to the increasing prevalence of fungal infection in the mouth, growing demand for cosmetic dentistry treatments and a huge patient population suffering from oral diseases across the Americas. According to the Centers for Disease Control and Prevention the US oral and dental health data 84.6% of children aged 2-17 years have a dental visit in the US in 2016 which increase the dental industry in this region.

Moreover, rising healthcare expenditure and the presence of developed economies like the US and Canada fuel the market growth.

Europe is second in the global dental industry market owing to a huge number of children’s suffering oral problems, increasing geriatric population, and presence of the developed economies like the UK, Italy, France, and others.  Asia-Pacific region is the fastest growing market owing to the presence of developing economies, a growing healthcare sector and rising geriatric population drive the market with the region. The Middle East & Africa has the least share in the global dental industry market owing to the presence of poor economies and stringent government policies, especially in the African region.

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

       TOC Continued….!

Browse Complete Report Details @

https://www.marketresearchfuture.com/reports/dental-industry-market-7637

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com